Trends in Biotechnology
Volume 21, Issue 2, February 2003, Pages 74-81
Journal home page for Trends in Biotechnology

LNA: a versatile tool for therapeutics and genomics

https://doi.org/10.1016/S0167-7799(02)00038-0Get rights and content

Abstract

Locked nucleic acid (LNA) is a nucleic acid analogue that displays unprecedented hybridization affinity towards complementary DNA and RNA. Structural studies have shown LNA to be an RNA mimic, fitting seamlessly into an A-type duplex geometry. Several reports have revealed LNA as a most promising molecule for the development of oligonucleotide-based therapeutics. For example, Tat-dependent transcription and telomerase activity have been efficiently suppressed by LNA oligomers, and efficient cleavage of highly structured RNA has been achieved using LNA-modified DNAzymes ('LNAzyme'). Furthermore, convincing examples of the application of LNA to nucleic acid diagnostics have been reported, including high capturing efficiencies and unambiguous scoring of single-nucleotide polymorphisms.

Section snippets

Recognition of single-stranded DNA and RNA

The hybridization properties of LNA oligonucleotides have been evaluated in several different sequences, ranging from six to ∼20-nucleotide long oligomers with various levels of LNA content (for reports with comprehensive tables, see for example 5, 9, 14, 15). Hybridization of LNA with either DNA or RNA targets has demonstrated unprecedented thermostabilities, shown by remarkable increases in melting points per LNA monomer introduced (ΔTm values): ΔTm=+1 – +8°C against DNA 5, 6, 9, 14, 16 and ΔT

Molecular structures of LNA hybrids

Several LNA–RNA and LNA–DNA hybrids have been structurally characterized by NMR spectroscopy and X-ray crystallography. In general, these hybrids retain the features common for native nucleic acid duplexes (i.e. usual Watson–Crick base pairing, nucleobases in the anti orientation, base stacking and a right-handed helical conformation).

NMR spectroscopic studies of three nonamer LNA–RNA hybrids, in which the LNA strand contained one, three and nine LNA monomers, respectively 17, 29, revealed

LNA and therapeutic applications

The use of oligonucleotide analogues for regulation of gene expression is a concept eagerly pursued because of its enormous therapeutic potential 34, 35. In principle, an antisense oligonucleotide (AO), complementary to a given mRNA, is introduced into the cell and binds to the mRNA, thereby inhibiting translation. There are several mechanisms by which an AO might silence the message of the target mRNA (e.g. inhibition or alteration of splicing, translational arrest, redirection of

LNA in diagnostics

Single-nucleotide mutations in the genetic code are the cause of several ailments. The traditional methods of scanning for single-nucleotide polymorphisms (SNPs) are generally time-consuming and difficult to automate because enzymatic digestion and/or gel electrophoresis are required. Easy-to-use SNP assays based on the LNA technology have been designed and implemented. These assays rely on the observation that single-nucleotide mismatch discrimination is better for LNA than for DNA (i.e. the

LNA as aptamers (decoys)

Aberrant activation and expression of genes, whose products are involved in initiation and progression of pathogenesis, cause several diseases. In recent years, strategies targeting transcription-activating proteins have emerged. One such strategy is the use of dsDNAs bearing the consensus binding sequence of a specific transcription factor. Once transfected into cells, these dsDNA aptamers, dubbed decoys, interact with the target factor. Interaction with the decoy results in incapacitation of

Conclusions and outlook

LNA is a general and versatile tool for high-affinity recognition of ssDNA, ssRNA and dsDNA. Not only can fully modified LNA be applied but so can, for example, LNA/DNA, LNA/RNA, LNA/2′-OMe-RNA and LNA/phosphorothioate-DNA chimeras. This unique freedom of LNA design offers the possibility of fine-tuning the hybridization of virtually any oligonucleotide and also the use of known oligonucleotide modifications and technologies in combination with LNA.

Several reports have recently appeared on the

Acknowledgements

We are grateful to the many collaborators who have contributed to the development and study of LNA. We acknowledge financial support from the Danish National Research Foundation, The Danish Research Agency and Exiqon A/S.

References (56)

  • J.-J. Toulmé

    New candidates for true antisense

    Nat. Biotechnol.

    (2001)
  • J.L. Childs

    Oligonucleotide directed misfolding of RNA inhibits Candida albicans group I intron splicing

    Proc. Natl. Acad. Sci. U. S. A.

    (2002)
  • H. Ørum

    Detection of the factor V Leiden mutation by direct allele-specific hybridization of PCR amplicons to photo-immobilized locked nucleic acids

    Clin. Chem.

    (1999)
  • N. Jacobsen

    Genotyping of the Apolipoprotein B R3500Q mutation using immobilized locked nucleic acid capture probes

    Clin. Chem.

    (2002)
  • A. Simeonov et al.

    Single nucleotide polymorphism genotyping using short, fluorescently labeled locked nucleic acid (LNA) probes and fluorescence polarization detection

    Nucleic Acids Res.

    (2002)
  • A. Bielinska

    Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

    Science

    (1990)
  • E. Uhlmann et al.

    Antisense oligonucleotides: a new therapeutic principle

    Chem. Rev.

    (1990)
  • S.M. Freier et al.

    The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA–RNA duplexes

    Nucleic Acids Res.

    (1997)
  • P. Herdewijn

    Conformationally restricted carbohydrate-modified nucleic acids and antisense technology

    Biochim. Biophys. Acta

    (1999)
  • S.K. Singh

    LNA (locked nucleic acids): synthesis and high-affinity nucleic acid recognition

    Chem. Commun.

    (1998)
  • A.A. Koshkin

    LNA (locked nucleic acids): synthesis of the adenine, cytosine, guanine, 5-methylcytosine, thymine and uracil bicyclonucleoside monomers, oligomerization, and unprecedented nucleic acid recognition

    Tetrahedron

    (1998)
  • S. Obika

    Stability and structural features of the duplexes containing nucleoside analogues with a fixed N-type conformation, 2′-O,4′-C-methyleneribonucleosides

    Tetrahedron Lett.

    (1998)
  • S.K. Singh et al.

    Universality of LNA-mediated high-affinity nucleic acid recognition

    Chem. Commun.

    (1998)
  • J. Wengel

    Synthesis of 3′-C- and 4′-C-branched oligonucleotides and the development of locked nucleic acid (LNA)

    Acc. Chem. Res.

    (1998)
  • J. Wengel

    LNA (locked nucleic acid) and the diastereoisomeric α-l-LNA: conformational tuning and high-affinity recognition of DNA/RNA targets

    Nucleosides Nucleotides Nucleic Acids

    (2001)
  • S. Obika

    Synthesis of 2′-O,4′-C-methyleneuridine and -cytidine. novel bicyclic nucleosides having a fixed C3′-endo sugar puckering

    Tetrahedron Lett.

    (1997)
  • A. Arzumanov

    Inhibition of HIV-1 Tat-dependent trans activation by steric block chimeric 2′-O-methyl–LNA oligoribonucleotides

    Biochemistry

    (2001)
  • L. Kværnø

    Synthesis of abasic locked nucleic acid and two seco-LNA derivatives and evaluation of their hybridization properties compared with their more flexible DNA counterparts

    J. Org. Chem.

    (2000)
  • Cited by (0)

    View full text